what class of medication is tirzepatide and Monjourno? | Bill Collins posted on the topic Tirzepatide vs. Ozempic: Comparing Diabetes
Description
Common side effects include nausea, vomiting, and diarrhea, which usually subside over time

[DOI] [PMC free article] [PubMed] [Google Scholar] 20.Secher A, Jelsing J, Baquero AF, et al

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK as Mounjaro for the treatment of type 2 diabetes mellitus and as Zepbound for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Improper reconstitution or storage can degrade the peptide, potentially reducing efficacy (requiring higher doses and more side effects) or introducing contaminants

Individuals should take the medication, in consultation with their health care provider, if they have this condition not if they are simply unhappy with their appearance and trying to lose a few pounds

Heather C
